Zhejiang Chimin Pharm Co Ltd (603222) — Strategic Asset Allocation Index
Zhejiang Chimin Pharm Co Ltd (603222) has a Strategic Asset Allocation Index of 73.8% as of June 2023. Strategic assets (PP&E of CN¥1.34 Billion plus long-term investments of CN¥-) total CN¥1.34 Billion, measured against net assets of CN¥1.82 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 603222 net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Zhejiang Chimin Pharm Co Ltd Strategic Asset Allocation Index (2011–2022)
This chart shows how Zhejiang Chimin Pharm Co Ltd's Strategic Asset Allocation Index has evolved across 12 annual periods from 2011 to 2022. As of June 2023, the index stands at 73.8%, representing strategic assets of CN¥1.34 Billion against net assets of CN¥1.82 Billion CNY. For live market cap and overall valuation, see how much is Zhejiang Chimin Pharm Co Ltd worth.
Annual Strategic Asset Allocation Index for Zhejiang Chimin Pharm Co Ltd (2011–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Zhejiang Chimin Pharm Co Ltd from 2011 to 2022, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Zhejiang Chimin Pharm Co Ltd book value and equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 76.0% | CN¥1.35 Billion | CN¥1.35 Billion | CN¥- | CN¥1.77 Billion | ▼ -12.3 pp |
| 2021 | 88.3% | CN¥1.21 Billion | CN¥1.21 Billion | CN¥- | CN¥1.37 Billion | ▼ -17.2 pp |
| 2020 | 105.6% | CN¥1.10 Billion | CN¥1.10 Billion | CN¥- | CN¥1.05 Billion | ▲ +9.5 pp |
| 2019 | 96.0% | CN¥1.03 Billion | CN¥1.03 Billion | CN¥- | CN¥1.07 Billion | ▼ -4.9 pp |
| 2018 | 100.9% | CN¥1.06 Billion | CN¥1.06 Billion | CN¥- | CN¥1.05 Billion | ▲ +25.6 pp |
| 2017 | 75.4% | CN¥699.81 Million | CN¥689.29 Million | CN¥10.52 Million | CN¥928.28 Million | ▲ +45.2 pp |
| 2016 | 30.2% | CN¥244.07 Million | CN¥244.07 Million | CN¥- | CN¥808.94 Million | ▲ +4.2 pp |
| 2015 | 25.9% | CN¥194.86 Million | CN¥194.86 Million | CN¥- | CN¥750.99 Million | ▼ -11.7 pp |
| 2014 | 37.7% | CN¥166.44 Million | CN¥166.44 Million | CN¥- | CN¥441.55 Million | ▲ +1.1 pp |
| 2013 | 36.6% | CN¥178.79 Million | CN¥178.79 Million | CN¥- | CN¥488.13 Million | ▼ -3.4 pp |
| 2012 | 40.1% | CN¥173.24 Million | CN¥173.24 Million | CN¥- | CN¥432.53 Million | ▼ -3.3 pp |
| 2011 | 43.4% | CN¥166.19 Million | CN¥166.19 Million | CN¥- | CN¥383.04 Million | — |